Insights

Atebrioz’s FDA approval for ultra-rare FOP puts HCP education on the clock. How 3D visualization of ALK2-driven bone growth helps rare-disease teams brief clinicians before October 2026 availability.

How Sephora Drop Shop turns TikTok discovery into a retailer-owned launch franchise—and what prestige brands need: drop-ready creative, inventory sequencing, and compliant LIVE + PDP claim packs.

FDA PreCheck pilot manufacturing picks Lilly, Regeneron, Fujifilm, Cellares, Kriya and two peers—what faster U.S. facility reviews mean for CGT programs, access, and cold chain.

Nutromics’ vancomycin microneedle patch won FDA Breakthrough Device designation in September 2026. What continuous TDM could mean for hospital pharmacy, stewardship ops, and vendor evaluation—before full clearance.